1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. GERON CORP.
Geron Corp.
XNAS: GERN

Geron Corp Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Geron Corp is a biopharmaceutical company focused on blood cancers. Its telomerase inhibitor, RYTELO (imetelstat), is approved in the United States and European Union for certain adult patients with lower-risk myelodysplastic syndromes (LR-MDS) with ...

Read More
1.46 -0.12 (-7.59%)
27.36% Fall from 52W High
17.4M
XNAS Volume

XNAS 07 May, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The latest board meeting for Geron Corp took place on 07 May 2026, for the purpose of Geron Corp First Quarter Earnings Results for 2026 See details
Durability score
Low Financial Strength
22.2 / 100
Valuation Score
Expensive Valuation
16.5 / 100
Momentum Score
Technically Neutral
50.2 / 100
Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM
Analyst Price Target
4
1Yr Price target upside is 174%
4 analysts

6

S

15

W

4

O

1

T

SWOT Analysis

Geron Corp Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..